New Haven, CTNCT05612594Now EnrollingIRB Ready

Sleep Apnea Clinical Trial in New Haven, CT

Access cutting-edge sleep apnea treatment through this phase 4 clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.

Sponsored by Yale University

Quick Self-Assessment

See if you qualify for this New Haven location

Preparing your pre-screening questions…

Expert Care in New Haven

Access sleep apnea specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related sleep apnea treatment provided free

Apply for This New Haven Location

Check if you qualify for this sleep apnea clinical trial in New Haven, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Haven

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Haven site if eligible
  4. 4Begin participation

About This Sleep Apnea Study in New Haven

The goal of this clinical trial is to test if bexagliflozin lowers the sleep apnea severity in adults who are overweight or obese with moderate to severe obstructive sleep apnea (OSA) compared with a placebo (look-alike substance that contains no active drug). The main question it aims to answer is: * If SGLT2i will reduce anatomic and physiologic traits, clinical measures of OSA and sleep deficiency in participants * If improvement in clinical measures are because of improvement in the anatom

Sponsor: Yale University

Who Can Participate

Inclusion Criteria

Able to provide informed consent and stated willingness to comply with all study procedures and availability for the duration of the study
Overweight or obese (body mass index 25-40 kg/m2)
Clinically confirmed diagnosis of obstructive sleep apnea by one of the following methods: a. Polysomnography: AHI ≥15/hour sleep or b. Home sleep apnea testing: Respiratory event index (REI) ≥15/hour sleep
AHI: apnea-hypopnea index (apneas + hypopneas / total sleep time in hours)

Exclusion Criteria

An individual who meets any of the following criteria will be excluded from participation in this study:
Known non-OSA related conditions associated with sleep disordered breathing (e.g., central disorder of hypersomnolence, neurological, neuromuscular, or pulmonary disorder)
Use of sleep-inducing medications (e.g. benzodiazepines, opiates, barbiturates)
Type 1 diabetes mellitus
History of diabetic ketoacidosis
Known hypersensitivity reaction to bexagliflozin or any of its constituents or any contraindication to bexagliflozin use
Severe, recurrent urinary tract or genital mycotic infections
eGFR\<30mL/min/1.73m2 at time of or within 4 weeks of enrollment in the study
Unable to complete/tolerate magnetic resonance imaging (MRI) due to severe claustrophobia or metallic implants.
Language barrier, mental incapacity, unwillingness or inability to understand.
Females of childbearing potential who are pregnant, breast-feeding or intend to become pregnant.
Currently or planning to take a SGLT2i prior to or during enrollment in the study
Currently or planning to follow a ketogenic diet pattern ("keto diet) prior to or during enrollment in the study
Currently or planning to follow an active weight loss program (including but not limited to use of supplements, medications, or surgery) prior to or during enrollment in the study
Currently or planning to follow an intermittent fasting diet plan prior to or during enrollment in the study
Currently or planning to take a GLP-1 receptor agonist prior to or during enrollment in the study .
Existing lower limb ulcer (due to diabetes or any cause)
Existing severe peripheral arterial disease with intermittent claudication and/or prior lower limb revascularization procedure
Concomitant administration of UGT inducers
Severe liver disease

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Haven?

Yes, this clinical trial (NCT05612594) has an active research site in New Haven, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sleep Apnea Treatment Options in New Haven, CT

If you're searching for sleep apnea treatment options in New Haven, CT, this clinical trial (NCT05612594) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Haven research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced sleep apnea specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sleep apnea clinical trials near you to find additional studies recruiting in your area.

More Lupus Trials in New Haven, CT

See all lupus clinical trials recruiting in New Haven — not just this study.

Browse Lupus Trials in New Haven →

Browse More Trials by Condition

Lupus TrialsSleep Apnea TrialsPrurigo Nodularis TrialsSystemic Lupus Erythematosus TrialsAll Conditions →

Ready to Join in New Haven?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Haven, CT